Ausgabe 3/2023
Inhalt (17 Artikel)
- Open Access
- short review
FlASHback—personal highlights regarding myelodysplastic syndrome from the 2022 ASH meeting
Verena Petzer, Dominik Wolf
- Open Access
- short review
ASH highlights 2022—multiple myeloma
Lina Z. Rüsing, Hermine Agis, Maria Krauth
- Open Access
- short review
New developments in radiation oncology for head and neck cancers
Christoph Resl, Petra Georg, Carmen Döller
- Open Access
- short review
Current systemic treatment options and new developments in palliative first-line treatment of head and neck squamous cell carcinoma
Florian Kocher, Andreas Seeber
- Open Access
- short review
How the long-term follow-up is organized in young adult survivors of childhood cancer
Edit Bardi, Leo Kager, Wolfgang Holter
- short review
Next generation drugs in urothelial cancer: adenoviruses in the treatment of BCG-unresponsive nonmuscle invasive bladder cancer
Dominik A. Barth, Martin Pichler
- Open Access
- short review
Lipid nanoparticles in the treatment of lung cancer—hype or hope?
Anna Mair, Fabienne Nocera, Dominik Wolf, Andreas Pircher
- Open Access
- leading article
Emerging molecular drugs for the treatment of gastroesophageal tumors
Aysegül Ilhan-Mutlu
- Open Access
- original report
Assessment of nutritional status using objective and subjective methods in Greek patients with cancer
Konstantina Vamvakari, Iliana Evangelou, Ioanna Panagiota Kalafati, Michail Kipouros, Rena I. Kosti, Arezina N. Kasti, Odysseas Androutsos
- case report
Hepatosplenic T-cell lymphoma with hemophagocytic lymphohistiocytosis, revealed by fever of unknown origin
Kaoutar Meliani, Noufissa Alami Dribi, Widad Rhandour, Afaf Amarti Riffi, Zineb Khammar, Rhyzlane Berrady
